Metraipolis › archive › dc_21c84ea3759d

Long-term effectiveness of fremanezumab in episodic and chronic migraine patients in clinical routine - 24-months results from the prospective… — Europe PMC PMID:41430103

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41430103
DOI
10.1186/s10194-[numero omesso]-x
License (as archived)
solo-consultazione
Archived
2026-11-07T11:16:51.065Z
SHA-256 of the archived text
e1b2ca84aaa6bce839de83eabf8a6c0b2c76edd8c4d7aab462dfb957ac57b482
Stable URL of this page
https://metraipolis.com/documento/dc_21c84ea3759d

How to cite

Long-term effectiveness of fremanezumab in episodic and chronic migraine patients in clinical routine - 24-months results from the prospective… — Europe PMC PMID:41430103 — Europe PMC (en), https://europepmc.org/article/MED/41430103 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_21c84ea3759d (Metraipolis archive dc_21c84ea3759d, sha256 e1b2ca84aaa6bce839de83eabf8a6c0b2c76edd8c4d7aab462dfb957ac57b482)
BibTeX
@misc{dc21c84ea3759d,
  title = {Long-term effectiveness of fremanezumab in episodic and chronic migraine patients in clinical routine - 24-months results from the prospective… — Europe PMC PMID:41430103},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41430103},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_21c84ea3759d; sha256 e1b2ca84aaa6bce839de83eabf8a6c0b2c76edd8c4d7aab462dfb957ac57b482},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41430103. Agents can read the archived copy with the MCP tool read_document.